Position in DGX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$77,149
+$76,954 QoQ
Shares Held
364
+36300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#885
of 1,090 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Davis Capital Management holds $1,940,421 across 13 Diagnostics & Research names. DGX ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
8,362 | $1,110,724 | |
| 2 | DHR |
Danaher Corp /De/
|
2,323 | $442,485 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
610 | $305,829 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
364 | $77,149 | |
| 5 | NTRA |
Natera, Inc.
|
3 | $814 | |
| 6 | WAT |
Waters Corp /De/
|
2 | $750 | |
| 7 | ILMN |
Illumina, Inc.
|
4 | $703 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3 | $579 |
All Filings in DGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,149 | 364 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $195 | 1 | Shares | Sole | 2026-04-16 | |
| 2025-09-30 | $190 | 1 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||